Retatrutide: My Experience and Side Effects
Published on July 29, 2026
Four weeks on retatrutide: how it affected my hunger, portion sizes, sweet cravings, and performance—and why I would approach it differently today.
GLP-1
What Is GLP-1 and How Do GLP-1 Receptor Agonists Work?
Published on July 27, 2026
GLP-1 is a gut hormone. How does it affect insulin, glucagon, hunger, and the stomach — and what is a GLP-1 receptor agonist?
Retatrutide in a Diet: Split Dosing, Lower Doses, and Why Not to Copy Clinical Trials
Published on July 10, 2026
Retatrutide trials target maximum weight loss in patients with obesity. A regular person in a diet phase often needs something different: moderate appetite control, lower doses, and fewer adverse effects. This is a harm-reduction analysis of split dosing, not medical advice.
Retatrutide: What It Is and Why All the Hype
Published on July 9, 2026
Retatrutide activates the GLP-1, GIP, and glucagon receptors. What have studies shown, why has it generated so much hype, and what do we still not know?